免疫检查点阻断通过扩增效应 CD8⁺ T 细胞克隆增强淋巴细胞清除性化疗诱导的抗肿瘤免疫
Immune Checkpoint Blockade Augments Lymphodepleting Chemotherapy-Induced Antitumor Immunity by Expanding Effector CD8+ T-cell Clones.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Spatial Proximity and Relative Distribution of Tumor-Infiltrating Lymphocytes and Macrophages Predict Survival in Melanoma.
Spatial Proximity and Relative Distribution of Tumor-Infiltrating Lymphocytes and Macrophages Predict Survival in Melanoma.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
肿瘤微环境在原发性皮肤黑色素瘤(CM)进展中发挥关键作用。TIL(肿瘤浸润淋巴细胞)密度的作用早已明确,但其空间分布及其与肿瘤相关巨噬细胞(TAM)的相互影响仍有争议。
本研究分析113例原发性CM中肿瘤细胞和免疫细胞之间的空间邻近关系,并评估其与无病生存期(DFS)及总生存期(OS)的相关性。队列包括II期患者79例、III期患者34例,Breslow厚度均>2 mm;患者中位年龄64岁,男性72例、女性41例。单变量模型显示,在20 μm半径范围内SOX10阳性黑色素瘤细胞与CD8+ TIL邻近度较高者DFS较长(HR 0.58,95% CI 0.36–0.93;P=0.025),OS也较长(HR 0.55,95% CI 0.32–0.92;P=0.023)。
多变量联合分析显示,与CD8+ TIL邻近度较低或CD163+ TAM邻近度较高的患者相比,在20 μm半径内SOX10阳性黑色素瘤细胞与CD8+ TIL邻近度较高或与CD163+ TAM邻近度较低者OS更长(校正HR 0.37,95% CI 0.14–0.96;P=0.04)。在92例患者的亚组分析中,对于前哨淋巴结(SLN)阴性患者,CD163+ TAM与CD8+ TIL邻近度高与DFS显著较差(校正HR 4.49,95% CI 1.73–11.64;P=0.002)和OS显著较差(校正HR 3.97,95% CI 1.37–11.49;P=0.01)相关。这些发现有助于识别厚型黑色素瘤且SLN阴性患者中的高风险人群。
本研究提示,临床结局评估不仅应量化免疫细胞密度,还应评估肿瘤细胞和免疫细胞各自及相互之间的空间分布。
Tumor microenvironment plays a crucial role in primary cutaneous melanoma (CM) progression. Although the role of tumor-infiltrating lymphocyte (TIL) density has been known for a long time, its spatial distribution and impact with or without tumor-associated macrophages (TAMs) remain controversial.
Herein, we investigated spatial proximity between tumor cells and immune cells in 113 primary CM and its correlation with disease-free (DFS) and overall survival (OS). The study cohort included clinical stage II (n = 79) and stage III (n = 34) primary CM with a Breslow thickness of >2 mm (with a median age of 64 years, including 72 men and 41 women).
In univariate models, patients with SOX10+ melanoma cells with high proximity to CD8+ TILs in a 20 m radius showed longer DFS (hazard ratio [HR], 0. 58; 95% CI, 0. 36-0. 93; P = . 025) and OS (HR, 0. 55; 95% CI, 0. 32-0. 92; P = . 023).
Furthermore, at multivariate combined analysis, patients with SOX10+ melanoma cells with high proximity to CD8+ TILs or low proximity to CD163+ TAMs in a 20 m radius showed an increased OS (aHR, 0. 37; 95% CI, 0. 14-0. 96; P = . 04) compared with melanoma patients with low proximity to CD8+ TILs or high proximity to CD163+ TAMs.
In a subgroup analysis including 92 patients, a significant negative impact on DFS (aHR, 4. 49; 95% CI, 1. 73-11. 64; P = . 002) and OS (aHR, 3. 97; 95% CI, 1. 37-11. 49; P = . 01) was observed in sentinel lymph node (SLN)-negative patients with a high proximity of CD163+ TAMs to CD8+ TILs.
These findings could help identify high-risk patients in the context of thick melanoma and a negative SLN.
Our study suggests the importance of quantifying not only the density of immune cells but also the individual and combined relative spatial distributions of tumor cells and immune cells for clinical outcomes in SLN-negative primary CM patients.
MEMBER ACCOUNT
登录成功会直接打开下一页。